Tell us about your product, market, and timeline — our specialists will design a testing programme that fits.
Our scientific team will help you identify the right tests, methods, and accreditations for your product or sample.
USFDA Inspected and DCGI approved analytical lab with an integrated Clinical Research Division.
The Gurugram (Manesar) facility is a 25,000 sq ft USFDA Inspected and DCGI approved (since 1995) analytical laboratory accredited by NABL under ISO/IEC 17025:2017 (Certificate TC-15532). The site uniquely integrates an analytical lab and a Clinical Research Division supporting BA / BE studies, bioanalytical testing, PK / PD studies, HRIPT, and SPF in-vivo claim substantiation per ISO 24444.
Area: 25,000 sq ft
NABL Certificate: NABL TC-15532
Validity: Valid until February 2029
Hours: Monday to Saturday, 9:00 AM to 6:00 PM
Phone: +91 74281 16100
Accredited under ISO/IEC 17025:2017
Pharmaceutical testing facility
Approved since 1995
Analytical lab + Clinical Research Division
NABL TC-15532 covers 21 accredited test entries across pharmaceutical, cosmetics and essential oils, and radiological-water scope. The Clinical Research Division operates separately from the NABL testing scope.
NABL-accredited pharmaceutical testing covering assay, dissolution, stability, and microbiological testing under USFDA Inspected protocols.
Physicochemical testing for cosmetics and essential oils, supporting product release and regulatory documentation.
Alpha and Beta emitter analysis in water samples for regulatory and operational reporting.
Co-located with the analytical lab, the Clinical Research Division conducts BA / BE, bioanalytical, PK / PD, HRIPT, and SPF in-vivo claim substantiation studies for pharmaceutical, nutraceutical, cosmetic, and AYUSH products.
Bioavailability and bioequivalence studies for generic and reformulated pharmaceutical products under DCGI-approved protocols.
Bioanalytical method development and validation for clinical sample analysis, supporting PK and PD data generation.
Pharmacokinetic and pharmacodynamic study conduct for pharmaceutical development and lifecycle management.
Human Repeat Insult Patch Test for cosmetic and personal care claim substantiation and sensitisation assessment.
SPF in-vivo testing per ISO 24444 for sunscreen and cosmetic claim substantiation.
Safety and efficacy studies for pharmaceutical, nutraceutical, cosmetic, and AYUSH products under regulatory protocols.
Accreditations & Approvals




















Analytical instrumentation across pharmaceutical assay, dissolution, bioanalytical, particle size, and thermal analysis workflows.
High-performance liquid chromatography with UV detection across pharmaceutical assay and impurity profiling.
Ultra-performance liquid chromatography for high-resolution analytical separations and rapid method workflows.
Liquid chromatography tandem mass spectrometry for bioanalytical sample quantitation, impurity profiling, and trace analysis.
Gas chromatography for residual solvents, volatile organics, and pharmaceutical assay workflows.
Differential scanning calorimetry for thermal analysis, polymorph identification, and stability characterisation.
Laser diffraction particle size analysis for solid dosage forms, suspensions, and inhalation products.
Atomic absorption spectroscopy for elemental analysis in pharmaceutical and cosmetic matrices.
Automated potentiometric titration for pharmacopoeial assay determinations and routine analytical workflows.
USP apparatus dissolution testing for solid and semi-solid dosage forms.
Pharmacopoeial disintegration testing for tablets, capsules, and oral solid dosage forms.
Moisture and water content determination for solid, semi-solid, and liquid samples.
Closed-vessel microwave digestion for heavy metals sample preparation across pharmaceutical and cosmetic matrices.
Temperature-controlled centrifugation for bioanalytical sample processing and clinical study workflows.
Quantitative assay, content uniformity, and routine determinations across pharmaceutical and cosmetic matrices.
Ultra-low temperature deep freezers for bioanalytical sample storage at clinical study temperatures.
Six buyer profiles use the Manesar facility for USFDA Inspected analytical work and integrated clinical research.
Pharmaceutical companies in the Gurugram-NCR corridor requiring USFDA Inspected lab reports for ANDA, NDA, and CDSCO submissions.
Clinical study sponsors requiring BA / BE, pharmacokinetic, and safety study conduct under DCGI-approved protocols.
Cosmetics brands requiring USFDA-backed stability and safety reports for international submissions and buyer due diligence.
Sunscreen and cosmetic brands requiring SPF in-vivo claim substantiation per ISO 24444 with human volunteer studies.
Nutraceutical and supplement brands requiring safety and efficacy studies via the Clinical Research Division.
AYUSH and herbal product manufacturers requiring safety, efficacy, and claim substantiation studies via the Clinical Research Division.
Four steps for lab samples. For clinical study enquiries, contact the Clinical Research Division separately.
Call your single point of contact at +91 74281 16100 to confirm the test scope, applicable standard, and sample quantity for your matrix.
Drop the sample at the IMT Manesar address or send by pre-approved courier. Each sample is bar coded on receipt and registered in YLIMS.
For clinical study enquiries (BA / BE, PK / PD, HRIPT, SPF in-vivo), contact the Clinical Research Division separately for protocol development and quotation.
Track your lab samples, status, and digital report via YLIMS. Standard TAT is 5 to 7 working days for analytical testing. Clinical study timelines follow study protocol.
Plot 136, Sector 5, IMT Manesar, Gurugram, Haryana 122052.
Coordinates: 28.3693, 76.9233
Open in Google Maps →See the national pharmaceutical testing service page, the Clinical Trials service page, or browse all lab locations.
National pharmaceutical testing service page with complete catalogue of methods, parameters, and supported pharmacopoeias.
Open →Phase II–IV clinical trials, BA / BE monitoring, and clinical research conducted from the Manesar facility.
Open →5 NABL-accredited testing laboratories across India.
Open →NABL TC-15532 accredited pharmaceutical testing with USFDA Inspected protocols and integrated Clinical Research Division. Standard analytical TAT 5 to 7 working days.
Download a practical testing guide tailored to your industry — checklists, parameters, and regulatory tips in one place.
Download Guide Request a Quote InsteadNo thanks, I'll keep browsing